Loading...
Docoh

CC Neuberger Principal Holdings III (PRPC)

Document and Entity Information

Document and Entity Information - shares6 Months Ended
Jun. 30, 2021Aug. 16, 2021
Document Information [Line Items]
Document Type10-Q
Document Quarterly Reporttrue
Document Transition Reportfalse
Document Period End DateJun. 30,
2021
Entity File Number001-39984
Entity Registrant NameCC NEUBERGER PRINCIPAL HOLDINGS III
Entity Incorporation, State or Country CodeE9
Entity Tax Identification Number98-1552405
Entity Address, Address Line One200 Park Avenue
Entity Address, City or Town58th FloorNew York
Entity Address State Or ProvinceNY
Entity Address, Postal Zip Code10166
City Area Code212
Local Phone Number355-5515
Entity Current Reporting StatusNo
Entity Interactive Data CurrentYes
Entity Filer CategoryNon-accelerated Filer
Entity Small Businesstrue
Entity Emerging Growth Companytrue
Entity Ex Transition Periodfalse
Entity Shell Companytrue
Entity Central Index Key0001821329
Current Fiscal Year End Date--12-31
Document Fiscal Year Focus2021
Document Fiscal Period FocusQ2
Amendment Flagfalse
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant
Document Information [Line Items]
Title of 12(b) SecurityUnits, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant
Trading SymbolPRPC.U
Security Exchange NameNYSE
Class A ordinary shares
Document Information [Line Items]
Title of 12(b) SecurityClass A ordinary shares included as part of the units
Trading SymbolPRPC
Security Exchange NameNYSE
Entity Common Stock, Shares Outstanding40,250,000
Redeemable warrants included as part of the units
Document Information [Line Items]
Title of 12(b) SecurityRedeemable warrants included as part of the units
Trading SymbolPRPC.WS
Security Exchange NameNYSE
Class B ordinary shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding15,062,500

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)Jun. 30, 2021Dec. 31, 2020
Current assets
Cash $ 1,006,362
Prepaid expenses1,280,790 $ 11,396
Total current assets2,287,152 11,396
Deferred offering costs associated with the proposed public offering82,343
Cash and investments held in Trust Account402,521,993
Total Assets404,809,145 93,739
Current liabilities:
Accounts payable41,979 33,175
Accrued expenses188,200
Due to related party99,286
Total current liabilities329,465 33,175
Deferred legal fees435,862 49,168
Working capital loan1,840,000
Deferred underwriting commissions14,087,500
Derivative liabilities29,158,500
Total liabilities45,851,327 82,343
Commitments and Contingencies
Class A ordinary shares, $0.0001 par value; 35,395,781 and 0 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively353,957,810
Shareholders' Equity:
Additional paid-in capital14,079,105 23,494
Accumulated deficit(9,081,089)(13,604)
Total shareholders' equity5,000,008 11,396
Total Liabilities and Shareholders' Equity404,809,145 93,739
Class A ordinary shares
Shareholders' Equity:
Ordinary shares486
Total shareholders' equity486 0
Class B ordinary shares
Shareholders' Equity:
Ordinary shares1,506 1,506
Total shareholders' equity $ 1,506 $ 1,506

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / sharesJun. 30, 2021Dec. 31, 2020
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized1,000,000 1,000,000
Preferred stock, shares issued0 0
Preferred stock, shares outstanding0 0
Class A ordinary shares
Ordinary shares, par value, (per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized500,000,000 500,000,000
Ordinary shares, shares issued4,854,219 0
Ordinary shares, shares outstanding4,854,219 0
Class A ordinary shares subject to redemption
Temporary equity, par value, (per share) $ 0.0001 $ 0.0001
Temporary equity, shares subject to possible redemption35,395,781 0
Temporary equity, redemption price per share $ 10 $ 10
Class B ordinary shares
Ordinary shares, par value, (per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized50,000,000 50,000,000
Ordinary shares, shares issued15,062,500 15,062,500
Ordinary shares, shares outstanding15,062,500 15,062,500

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)3 Months Ended6 Months Ended
Jun. 30, 2021Jun. 30, 2021
General and administrative expense $ 350,908 $ 801,808
Loss from operations(350,908)(801,808)
Other income (expense):
Change in fair value of derivative asset and liabilities(3,674,500)(7,551,500)
Financing costs(736,170)
Investment income on investments held in Trust Account1,465 21,993
Total other income (expense)(3,673,035)(8,265,677)
Net loss $ (4,023,943) $ (9,067,485)
Class A ordinary shares
Other income (expense):
Basic and diluted weighted average shares outstanding40,250,000 40,250,000
Basic and diluted net income (loss) per ordinary share $ 0 $ 0
Class B ordinary shares
Other income (expense):
Basic and diluted weighted average shares outstanding15,062,500 14,808,702
Basic and diluted net income (loss) per ordinary share $ (0.27) $ (0.61)

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)Class A ordinary sharesClass B ordinary sharesAdditional Paid-in CapitalAccumulated DeficitTotal
Balance at the beginning at Dec. 31, 2020 $ 0 $ 1,506 $ 23,494 $ (13,604) $ 11,396
Balance at the beginning (in shares) at Dec. 31, 202015,062,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of units in initial public offering, gross $ 4,025 390,098,975 390,103,000
Sale of units in initial public offering, gross (in shares)40,250,000
Offering costs(22,089,093)(22,089,093)
Shares subject to possible redemption $ (3,580)(357,978,180)(357,981,760)
Shares subject to possible redemption (in shares)(35,798,176)
Net loss(5,043,542)(5,043,542)
Balance at the end at Mar. 31, 2021 $ 445 $ 1,506 10,055,196 (5,057,146)5,000,001
Balance at the end (in shares) at Mar. 31, 20214,451,824 15,062,500
Balance at the beginning at Dec. 31, 2020 $ 0 $ 1,506 23,494 (13,604)11,396
Balance at the beginning (in shares) at Dec. 31, 202015,062,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss(9,067,485)
Balance at the end at Jun. 30, 2021 $ 486 $ 1,506 14,079,105 (9,081,089)5,000,008
Balance at the end (in shares) at Jun. 30, 20214,854,219 15,062,500
Balance at the beginning at Mar. 31, 2021 $ 445 $ 1,506 10,055,196 (5,057,146)5,000,001
Balance at the beginning (in shares) at Mar. 31, 20214,451,824 15,062,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares subject to possible redemption $ 41 4,023,909 4,023,950
Shares subject to possible redemption (in shares)402,395
Net loss(4,023,943)(4,023,943)
Balance at the end at Jun. 30, 2021 $ 486 $ 1,506 $ 14,079,105 $ (9,081,089) $ 5,000,008
Balance at the end (in shares) at Jun. 30, 20214,854,219 15,062,500

UNAUDITED CONDENSED STATEMENT O

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS6 Months Ended
Jun. 30, 2021USD ($)
Cash Flows from Operating Activities:
Net loss $ (9,067,485)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative asset and liabilities7,551,500
Financing costs736,170
Interest income on investments held in Trust Account(21,993)
Changes in operating assets and liabilities:
Prepaid expenses(1,269,394)
Accounts payable41,979
Accrued expenses78,200
Due to related party99,286
Deferred legal fees117,862
Net cash used in operating activities(1,733,875)
Cash Flows from Investing Activities:
Cash deposited in Trust Account(402,500,000)
Net cash used in investing activities(402,500,000)
Cash Flows from Financing Activities:
Repayment of note payable to related parties(181,088)
Proceeds from working capital loan1,000,000
Proceeds received from initial public offering, gross402,500,000
Proceeds received from private placement10,050,000
Offering costs paid(8,128,675)
Net cash provided by financing activities405,240,237
Net Change in Cash1,006,362
Cash - end of the period1,006,362
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accrued expenses110,000
Offering costs paid by related party under promissory note147,913
Accounts payable paid by related party under promissory note33,175
Deferred legal fees268,832
Deferred underwriting commissions14,087,500
Value of Class A ordinary shares subject to possible redemption342,987,200
Change in value of Class A ordinary shares subject to possible redemption $ 10,970,610

Description of Organization and

Description of Organization and Business Operations6 Months Ended
Jun. 30, 2021
Description of Organization and Business Operations
Description of Organization and Business OperationsNote 1 - Description of Organization and Business Operations CC Neuberger Principal Holdings III (the “Company”) is a newly incorporated blank check company incorporated in the Cayman Islands on July 24, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet selected (“Business Combination”). The Company may pursue a Business Combination in any industry or sector. As of June 30, 2021, the Company had not yet commenced operations. All activity for the period from July 24, 2020 (inception) through June 30, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below, and, since the closing of the Initial Public Offering, a search for a business combination candidate. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is CC Neuberger Principal Holdings III Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on February 2, 2021. On February 5, 2021, the Company consummated its Initial Public Offering of 40,250,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 5,250,000 additional Units to cover the underwriters’ over-allotment (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $402.5 million, and incurring offering costs of approximately $22.7 million, of which approximately $14.1 million was for deferred underwriting commissions (Note 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 10,050,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $10.1 million (Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $402.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) and will be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in Trust). However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. ​ The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board’s (“FASB”)Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by applicable law or stock exchange listing requirement, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to the Initial Public Offering (the “Initial Shareholders”) agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, executive officers, directors and director nominees agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or February 5, 2023, (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and net of taxes paid or payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and net of taxes paid or payable). The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per Public Share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the Trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Capital Resources As of June 30, 2021, the Company had approximately $1.0 million in its operating bank account and working capital of approximately $2.0 million. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to purchase Founder Shares (see Note 4), and a loan from the Sponsor of approximately $181,000 under the Note (see Note 4). The Note is due on demand and remains outstanding to date. Subsequent from the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company Working Capital Loans (as defined in Note 4) as may be required. Based on the foregoing, management believes that the Company will have borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. ​

Summary of Significant Accounti

Summary of Significant Accounting Policies6 Months Ended
Jun. 30, 2021
Summary of Significant Accounting Policies
Summary of Significant Accounting PoliciesNote 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Current Report on Form 8-K and the final prospectus filed by the Company with the SEC on February 11, 2021 and February 4, 2021, respectively, and the unaudited financial statements and notes thereto included in the Form10-Q filed by the Company with the SEC on May 25, 2021. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. ​ Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of June 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had approximately $1.0 million in cash and did not have any additional cash equivalents as of June 30, 2021. Investment Securities Held in Trust Account Upon the closing of the Initial Public Offering and the Private Placement, the Company was required to place net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement in a Trust Account, which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by management of the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account. Investments held in Trust Account are classified as trading securities, which are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of trading securities is included in investment income on Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information, other than for investments in open-ended money market funds with published daily net asset values (“NAV”), in which case the Company uses NAV as a practical expedient to fair value. The NAV on these investments is typically held constant at $1.00 per unit. Use of Estimates The preparation of financial statement in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, including, but not limited to, derivative liabilities, at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheet. Fair Value Measurements The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Working Capital Loan The Company has elected the fair value option to account for its working capital loan with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in the fair value of the conversion feature are recorded as change in the fair value of working capital loan on the condensed statement of operations. The fair value of the conversion feature is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability. Derivative Assets and Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The warrants issued in the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities and the Company entered into a Forward Purchase Agreement. The Forward Purchase Agreement provides for the purchase of up to $200,000,000 of units, with each unit consisting of one Class A ordinary share and three-twentieths For equity-linked contracts that are classified as assets or liabilities, we record the fair value of the equity-linked contracts at each condensed balance sheet date and record the change in the condensed statements of operations as a (gain) loss on change in fair value of derivative liabilities. Our public warrants are valued using a binomial lattice pricing model and have subsequently been measured based on the listed market price of such warrants. Our Private Placement Warrants are valued using a Black-Scholes pricing model. Our Forward Purchase Agreement is valued utilizing observable market prices for public shares and warrants, relative to the present value of contractual cash proceeds, each adjusted for the probability of executing a successful business combination. The assumptions used in preparing these models include estimates such as volatility, contractual terms, discount rates, dividend rate, expiration dates and risk-free rates. The estimates used to calculate the fair value of our derivative assets and liabilities change at each balance sheet date based on our stock price and other assumptions described above. If our assumptions change or we experience significant volatility in our stock price or interest rates, the fair value calculated from one balance sheet period to the next could be materially different. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting discounts and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the condensed statement of operations. Offering costs associated with the Class A ordinary shares were charged to shareholders’ equity upon the completion of the Initial Public Offering. ​ Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 35,395,781 and 0, respectively, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheet. Income Taxes FASB Topic ASC 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021 and December 31, 2020, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net loss per ordinary shares Net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 18,100,000 Class A ordinary shares in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s unaudited condensed statements of operations include a presentation of income or loss per share for ordinary shares subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Class A ordinary shares for the period is calculated by dividing the gain on marketable securities, dividends and interest held in Trust Account, by the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per share, basic and diluted for Class B ordinary shares for the period is calculated by dividing the net loss, less net gain attributable to Class A ordinary shares, resulting in an adjusted net loss, by the weighted average number of Class B ordinary shares outstanding for the periods. Reclassifications Certain prior year amounts have been reclassified in these condesned financial statements to confirm to the current year presentation. Recent Adopted Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statement.

Initial Public Offering

Initial Public Offering6 Months Ended
Jun. 30, 2021
Initial Public Offering
Initial Public OfferingNote 3 - Initial Public Offering On February 5, 2021, the Company consummated its Initial Public Offering of 40,250,000 Units, including 5,250,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $402.5 million, and incurring offering costs of approximately $22.7 million, of which approximately $14.1 million was for deferred underwriting commissions. Each Unit consists of one Class A ordinary share and one

Related Party Transactions

Related Party Transactions6 Months Ended
Jun. 30, 2021
Related Party Transactions
Related Party TransactionsNote 4 - Related Party Transactions Forward Purchase Agreement In connection with the consummation of the Initial Public Offering, the Company entered into the Forward Purchase Agreement with Neuberger Berman Opportunistic Capital Solutions Master Fund LP (“NBOKS”), a member of the Sponsor, which provided for the purchase of up to $200,000,000 of units (the “Forward Purchase Units”), with each Unit consisting of one Class A ordinary share (the “Forward Purchase Shares”) and three-twentieths Founder Shares On August 14, 2020, the Company issued an aggregate of 22,250,000 Class B ordinary shares to the Sponsor in exchange for a $25,000 payment from the Sponsor to cover for certain expenses on behalf of the Company, or approximately $0.001 per share (the “Founder Shares”). On January 13, 2021, the Sponsor irrevocably surrendered to the Company for cancellation and for nil consideration 7,187,500 Class B ordinary shares resulting in 15,062,500 Class B ordinary shares outstanding. On January 14, 2021 and June 24, 2021, respectively, the Sponsor transferred 40,000 Founder Shares to each Keith W. Abell and Joel Hackney, Jr., the independent director nominee. The holders of the Founder Shares agreed to forfeit up to an aggregate of 1,312,500 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the number of Founder Shares would equal 20% of the Company’s issued and outstanding shares after the Initial Public Offering plus the number of Class A ordinary shares to be sold pursuant to any forward purchase agreement to be entered into in connection with the Initial Public Offering (the “Forward Purchase Agreement”) as described below. On February 5, 2021, the underwriters fully exercised its over-allotment option; thus, these 1,312,500 Founder Shares were no longer subject to forfeiture. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination and (ii) subsequent to the initial Business Combination (x) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property or (y) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 30 Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 10,050,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $10.1 million. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. Certain proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On August 14, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing, unsecured and due upon the closing of the Initial Public Offering. As of February 5, 2021, the Company borrowed approximately $181,000 under the Note. The loan balance was repaid in full as of June 8, 2021. On May 20, 2021, the Company issued an unsecured promissory note (the “Note”) in the principal amount of $1,000,000 to the Sponsor. The Note does not bear interest and is repayable in full upon consummation of the Company’s Business Combination. If the Company does not complete a Business Combination, the Note shall not be repaid and all amounts owed under it will be forgiven. Upon the consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal balance of the Note, in whole or in part, into private placement warrants, at a price of $1.00 per private placement warrant. The Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of June 30, 2021, $1.0 million was drawn on the working capital loan, presented at its fair value of approximately $1.8 million on the accompanying unaudited condensed balance sheets. As of December 31, 2020, the Company had no borrowings under the Working Capital Loans. Administrative Support Agreement Commencing on the effective date of the registration statement on Form S-1 related to the Initial Public Offering through the earlier of consummation of the initial Business Combination and the Company’s liquidation, we reimburse the Sponsor for office space, secretarial and administrative services provided to us in the amount of $20,000 per month. The Company incurred approximately $60,000 and $99,000 in general and administrative expenses in the accompanying condensed statements of operations for the three and six months ended June 30, 2021, respectively, and approximately $99,000 and $0 was included in due to related party at June 30, 2021 and December 31, 2020, respectively.

Commitments and Contingencies

Commitments and Contingencies6 Months Ended
Jun. 30, 2021
Commitments and Contingencies
Commitments and ContingenciesNote 5 - Commitments and Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement entered into upon the closing date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the prospectus of the Initial Public Offering to purchase up to 5,250,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On February 5, 2021, the underwriters fully exercised their over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per Unit, or approximately $8.1 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, the underwriters were entitled to a deferred underwriting commission of $0.35 per unit, or approximately $14.1 million in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Deferred Legal Fees The Company entered into an engagement letter to obtain legal advisory services, pursuant to which the Company’s legal counsel agreed to defer their fees until the closing of the initial Business Combination. As of June 30, 2021 and December 31, 2020, the Company recorded an aggregate of approximately $436,000 and $49,200, respectively, in connection with such arrangement as deferred legal fees in the accompanying condensed balance sheet. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Shareholders' Equity

Shareholders' Equity6 Months Ended
Jun. 30, 2021
Shareholders' Equity
Shareholders' EquityNote 6 - Shareholders’ Equity Preference Shares— outstanding Class A Ordinary Shares— issued outstanding Class B Ordinary Shares— outstanding Holders of the Company’s Class B ordinary shares are entitled to one vote for each share. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination, or earlier at the option of the holder thereof, on a one-for-one basis. However, if additional Class A ordinary shares or any other equity-linked securities (as defined below) are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as converted basis, 20% of the sum of (i) the total number of ordinary shares outstanding upon completion of the Initial Public Offering plus (ii) the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination (including any Class A ordinary shares to be sold pursuant to a Forward Purchase Agreement, but not any warrants sold pursuant to a Forward Purchase Agreement), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans, provided that such conversion of Class B ordinary shares will never occur on a less than one-for-one basis. Any conversion of Class B ordinary shares described herein will take effect as a redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law.

Derivative Liabilities

Derivative Liabilities6 Months Ended
Jun. 30, 2021
Derivative Liabilities
Derivative LiabilitiesNote 7 - Derivative Liabilities Warrants As of June 30, 2021, the Company has 8,050,000 Public Warrants and 10,050,000 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below with respect to registration, or a valid exemption from registration is available. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue a Class A ordinary share upon exercise of a Public Warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. ​ The Company agreed that as soon as practicable, but in no event later than twenty Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00 . Once the warrants become exercisable, the Company may redeem the Public Warrants (except with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption; and ● if, and only if, the reported closing price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00 Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “Fair Market Value” of the Company’s Class A ordinary shares; and ● if, and only if, the last reported sale price (the “closing price”) of the Company’s Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuance of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company has not completed a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Forward purchase agreement The Forward Purchase Agreement provides for the purchase of up to $200,000,000 of units, with each unit consisting of one Class A ordinary share (the “Forward Purchase Shares”) and three-twentieths

Fair Value Measurements

Fair Value Measurements6 Months Ended
Jun. 30, 2021
Fair Value Measurements
Fair Value MeasurementsNote 8 - Fair Value Measurements A reconciliation of the beginning and ending balances of the derivative assets and liabilities is summarized below: ​ ​ ​ ​ ​ ​ Liabilities Balance at December 31, 2020 ​ $ — Acquisition date fair value of derivatives: ​ Public warrants issued in the initial public offering ​ 12,397,000 Private placement warrants issued in connection with the initial public offering (a) ​ 20,200,500 Forward purchase agreement (b) ​ 9,138,000 Total acquisition date fair value of derivative liabilities ​ 41,735,500 Change in fair value of warrant liabilities ​ (3,882,000) Change in fair value of forward purchase agreement ​ (8,695,000) Balance at June 30, 2021 ​ 29,158,500 (a) The initial fair value of the private warrants issued in connection with the initial public offering includes $10.2 million in excess fair value over the warrant price which is reflected in change in fair value of derivative warrant liabilities in the statement of operations. (b) The initial fair value of the forward purchase agreement is reflected in change in fair value of warrant liabilities in the statement of operations. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Significant Other Significant Other ​ ​ Active Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account - U.S. Treasury Securities (1) $ 350,960,920 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan ​ $ — ​ $ — ​ $ 1,840,000 Derivative warrant liabilities - public ​ $ 10,223,500 ​ $ — ​ $ — Derivative warrant liabilities - private ​ $ — ​ $ — ​ $ 18,492,000 Derivative liabilities - Forward purchase agreement ​ $ — ​ $ — ​ $ 443,000 (1) - Excludes $50,001,832 of investments in an open-ended money market fund, in which the Company uses NAV as a practical expedient to fair value and $1,559,241 in cash at June 30, 2021. The change in the fair value of the Level 3 derivative warrant liabilities for the period from January 13, 2021 (inception) through June 30, 2021 is summarized as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant Forward purchase Total derivative ​ ​ liabilities ​ agreement ​ (assets) liabilities Derivative (assets) liabilities at December 31, 2020 ​ $ — ​ $ — ​ $ — Issuance of Public and Private Placement Warrants ​ 22,447,000 ​ — ​ 22,447,000 Initial value of forward purchase agreement recognized as change in fair value of derivative assets and liabilities ​ — ​ 9,138,000 ​ 9,138,000 Initial excess fair value of Private Placement Warrants recognized in additional paid-in-capital ​ 10,150,500 ​ — ​ 10,150,500 Change in fair value of derivative warrant liabilities ​ (5,149,500) ​ — ​ (5,149,500) Change in fair value of forward purchase agreement ​ — ​ (10,262,000) ​ (10,262,000) Transfer of Public Warrants to Level 1 ​ (9,257,500) ​ — ​ (9,257,500) Derivative (assets) liabilities at March 31, 2021 ​ 18,190,500 ​ (1,124,000) ​ 17,066,500 Change in fair value of derivative warrant liabilities ​ 301,500 ​ — ​ 301,500 Change in fair value of forward purchase agreement ​ — ​ 1,567,000 ​ 1,567,000 Derivative (assets) liabilities at June 30, 2021 ​ 18,492,000 ​ 443,000 ​ 18,935,000 ​ The change in the fair value of the working capital loan measured with Level 3 inputs for the six months ended June 30, 2021 is summarized as follows: ​ ​ ​ ​ ​ Fair value at January 1, 2021 $ — Initial fair value of working capital loan ​ 1,000,000 Change in fair value of working capital loan ​ 840,000 Fair value of working capital loan at June 30, 2021 ​ $ 1,840,000 ​ Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in March 2021, when the Public Warrants were separately listed and traded. There were no other transfers Level 1 instruments include investments in money market funds and U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. ​ The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially measured at fair value using a binomial / lattice model for the public warrants and the Black-Scholes Option Pricing Model for the private warrants. The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such warrants, a Level 1 measurement, since March 2021. The Company’s Private Placement Warrants are valued a using Black-Scholes pricing model. The Company’s working capital loan is valued using the value of the private placement warrants assuming it converts at $1.00 per warrant. The company’s Forward Purchase Agreement is valued utilizing observable market prices for public shares and warrants, relative to the present value of contractual cash proceeds, each adjusted for the probability of executing a successful business combination. For the three and six months ended June 30, 2021, the Company recognized a loss on the statements of operations resulting from an increase in the fair value of liabilities of approximately $2.8 million and $6.7, respectively, million presented as change in fair value of derivative liabilities on the accompanying condensed statement of operations. ​ The valuation methodologies for the warrants, working capital loan and forward purchase agreement included in Derivative Liabilities include certain significant unobservable inputs, resulting in such valuations to be classified as Level 3 in the fair value measurement hierarchy. The methodologies include a probability of a successful business combination, which was determined to be 80% as of June 30, 2021. The methodologies also include an expected merger date, which was set as August 5, 2022, which is 18 months after the Initial Public Offering date. The warrant valuation models also include expected volatility, which differ between public and private placement warrants and can vary further depending on where the Company stands in identifying a business combination target. For public warrants and when such warrants have observed pricing in the public markets, we back-solved for the volatility input to our pricing model such that the resulting value equals the observed price. For public warrants and when such warrants are not yet trading and we do not have observed pricing in public markets, we assume a volatility based on research on SPAC warrants and the implied volatilities shortly after they start trading. The volatility of the private placement warrants vary depending on the specific characteristics of the public and private placement warrants. Prior to the announcement of a merger, we assume a volatility based on the median volatility of the Russell 3000 constituents. After the announcement of a proposed business combination and in cases where the public warrants are subject to the make-whole table, then we assume a volatility based on the volatility of the target company’s peer group. ​ The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: ​ ​ ​ ​ ​ ​ ​ As of June 30, Private Warrants ​ 2021 Stock price ​ $ 9.78 ​ Volatility ​ 30.0 % Expected life of the options to convert ​ 5.5 ​ Risk-free rate ​ 1.0 % Dividend yield ​ 0.0 % ​ ​ ​ ​ ​ ​ ​ As of June 30, Forward Purchase Agreements ​ 2021 Stock price ​ $ 9.78 ​ Probability of Merger Closing ​ 80.0 % Discount Term ​ 1.10 ​ Risk-free rate ​ 0.09 % ​

Subsequent Events

Subsequent Events6 Months Ended
Jun. 30, 2021
Subsequent Events
Subsequent EventsNote 9 - Subsequent Events Management has evaluated subsequent events to determine if events or transactions occurring through August 16, 2021, the date the financial statements were issued, require potential adjustment to or disclosure in the financial statements and has concluded that all such events that would require recognition or disclosure have been recognized or disclosed. ​

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)6 Months Ended
Jun. 30, 2021
Summary of Significant Accounting Policies
Basis of PresentationBasis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Current Report on Form 8-K and the final prospectus filed by the Company with the SEC on February 11, 2021 and February 4, 2021, respectively, and the unaudited financial statements and notes thereto included in the Form10-Q filed by the Company with the SEC on May 25, 2021.
Emerging Growth CompanyEmerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. ​ Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Concentration of Credit RiskConcentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of June 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash EquivalentsCash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had approximately $1.0 million in cash and did not have any additional cash equivalents as of June 30, 2021.
Investment Securities Held in Trust AccountInvestment Securities Held in Trust Account Upon the closing of the Initial Public Offering and the Private Placement, the Company was required to place net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement in a Trust Account, which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by management of the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account. Investments held in Trust Account are classified as trading securities, which are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of trading securities is included in investment income on Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information, other than for investments in open-ended money market funds with published daily net asset values (“NAV”), in which case the Company uses NAV as a practical expedient to fair value. The NAV on these investments is typically held constant at $1.00 per unit.
Use of EstimatesUse of Estimates The preparation of financial statement in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, including, but not limited to, derivative liabilities, at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.
Fair Value of Financial InstrumentsFair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheet.
Fair Value MeasurementsFair Value Measurements The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Working Capital LoansWorking Capital Loan The Company has elected the fair value option to account for its working capital loan with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in the fair value of the conversion feature are recorded as change in the fair value of working capital loan on the condensed statement of operations. The fair value of the conversion feature is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability.
Derivative Assets and LiabilitiesWorking Capital Loan The Company has elected the fair value option to account for its working capital loan with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in the fair value of the conversion feature are recorded as change in the fair value of working capital loan on the condensed statement of operations. The fair value of the conversion feature is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability.
Offering Costs Associated with the Initial Public OfferingOffering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting discounts and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the condensed statement of operations. Offering costs associated with the Class A ordinary shares were charged to shareholders’ equity upon the completion of the Initial Public Offering. ​
Class A Ordinary Shares Subject to Possible RedemptionClass A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 35,395,781 and 0, respectively, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheet.
Income TaxesIncome Taxes FASB Topic ASC 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021 and December 31, 2020, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net loss per ordinary sharesNet loss per ordinary shares Net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 18,100,000 Class A ordinary shares in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s unaudited condensed statements of operations include a presentation of income or loss per share for ordinary shares subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Class A ordinary shares for the period is calculated by dividing the gain on marketable securities, dividends and interest held in Trust Account, by the weighted average number of Class A ordinary shares outstanding for the periods. Net loss per share, basic and diluted for Class B ordinary shares for the period is calculated by dividing the net loss, less net gain attributable to Class A ordinary shares, resulting in an adjusted net loss, by the weighted average number of Class B ordinary shares outstanding for the periods.
ReclassificationsReclassifications Certain prior year amounts have been reclassified in these condesned financial statements to confirm to the current year presentation.
Recent Adopted Accounting StandardsReclassifications Certain prior year amounts have been reclassified in these condesned financial statements to confirm to the current year presentation.
Recent Adopted Accounting StandardsRecent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statement.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)6 Months Ended
Jun. 30, 2021
Fair Value Measurements
Summary of reconciliation of the beginning and ending balances of the derivative assets and liabilities​ ​ ​ ​ ​ ​ Liabilities Balance at December 31, 2020 ​ $ — Acquisition date fair value of derivatives: ​ Public warrants issued in the initial public offering ​ 12,397,000 Private placement warrants issued in connection with the initial public offering (a) ​ 20,200,500 Forward purchase agreement (b) ​ 9,138,000 Total acquisition date fair value of derivative liabilities ​ 41,735,500 Change in fair value of warrant liabilities ​ (3,882,000) Change in fair value of forward purchase agreement ​ (8,695,000) Balance at June 30, 2021 ​ 29,158,500 (a) The initial fair value of the private warrants issued in connection with the initial public offering includes $10.2 million in excess fair value over the warrant price which is reflected in change in fair value of derivative warrant liabilities in the statement of operations. (b) The initial fair value of the forward purchase agreement is reflected in change in fair value of warrant liabilities in the statement of operations.
Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Significant Other Significant Other ​ ​ Active Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account - U.S. Treasury Securities (1) $ 350,960,920 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan ​ $ — ​ $ — ​ $ 1,840,000 Derivative warrant liabilities - public ​ $ 10,223,500 ​ $ — ​ $ — Derivative warrant liabilities - private ​ $ — ​ $ — ​ $ 18,492,000 Derivative liabilities - Forward purchase agreement ​ $ — ​ $ — ​ $ 443,000 (1) - Excludes $50,001,832 of investments in an open-ended money market fund, in which the Company uses NAV as a practical expedient to fair value and $1,559,241 in cash at June 30, 2021.
Summary of change in the fair value of the Level 3 derivative warrant liabilities​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant Forward purchase Total derivative ​ ​ liabilities ​ agreement ​ (assets) liabilities Derivative (assets) liabilities at December 31, 2020 ​ $ — ​ $ — ​ $ — Issuance of Public and Private Placement Warrants ​ 22,447,000 ​ — ​ 22,447,000 Initial value of forward purchase agreement recognized as change in fair value of derivative assets and liabilities ​ — ​ 9,138,000 ​ 9,138,000 Initial excess fair value of Private Placement Warrants recognized in additional paid-in-capital ​ 10,150,500 ​ — ​ 10,150,500 Change in fair value of derivative warrant liabilities ​ (5,149,500) ​ — ​ (5,149,500) Change in fair value of forward purchase agreement ​ — ​ (10,262,000) ​ (10,262,000) Transfer of Public Warrants to Level 1 ​ (9,257,500) ​ — ​ (9,257,500) Derivative (assets) liabilities at March 31, 2021 ​ 18,190,500 ​ (1,124,000) ​ 17,066,500 Change in fair value of derivative warrant liabilities ​ 301,500 ​ — ​ 301,500 Change in fair value of forward purchase agreement ​ — ​ 1,567,000 ​ 1,567,000 Derivative (assets) liabilities at June 30, 2021 ​ 18,492,000 ​ 443,000 ​ 18,935,000
Schedule of changes in fair value of working capital loan​ ​ ​ ​ ​ Fair value at January 1, 2021 $ — Initial fair value of working capital loan ​ 1,000,000 Change in fair value of working capital loan ​ 840,000 Fair value of working capital loan at June 30, 2021 ​ $ 1,840,000
Schedule of quantitative information regarding Level 3 fair value measurements inputs​ ​ ​ ​ ​ ​ ​ As of June 30, Private Warrants ​ 2021 Stock price ​ $ 9.78 ​ Volatility ​ 30.0 % Expected life of the options to convert ​ 5.5 ​ Risk-free rate ​ 1.0 % Dividend yield ​ 0.0 % ​ ​ ​ ​ ​ ​ ​ As of June 30, Forward Purchase Agreements ​ 2021 Stock price ​ $ 9.78 ​ Probability of Merger Closing ​ 80.0 % Discount Term ​ 1.10 ​ Risk-free rate ​ 0.09 %

Description of Organization a_2

Description of Organization and Business Operations - Financing (Details)Feb. 05, 2021USD ($)D$ / sharessharesJun. 30, 2021USD ($)shares
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, gross (in shares) | shares40,250,000
Share price (in US$ per share) | $ / shares $ 10
Proceeds from issuance of shares $ 402,500,000
Incurred offering costs22,700,000
Underwriting commissions14,100,000
Principal deposited in Trust Account $ 402,500,000
Minimum market value of acquiree to net asset held in Trust Account (as a percent)80.00%
Minimum post-business combination ownership (as a percent)50.00%
Minimum net tangible asset upon consummation of business combination $ 5,000,001
Minimum percentage of shares requiring prior consent by entity15.00%
Public shares to be redeemed if business combination is not completed (as a percent)100.00%
Threshold period from closing of public offering the company is obligated to complete business combination24 months
Threshold business days for redemption of shares of trust account | D10
Maximum net interest to pay dissolution expenses $ 100,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, gross (in shares) | shares5,250,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued (in shares) | shares10,050,000
Price of warrants (in dollars per share) | $ / shares $ 1
Proceeds from issuance of warrants $ 10,100,000
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued (in shares) | shares10,050,000
Proceeds from issuance of warrants $ 10,100,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, gross (in shares) | shares5,250,000
Public Shares
Subsidiary, Sale of Stock [Line Items]
Share price (in US$ per share) | $ / shares $ 10

Description of Organization a_3

Description of Organization and Business Operations - Liquidity (Details) - USD ($)6 Months Ended
Jun. 30, 2021Feb. 05, 2021
Related Party Transaction [Line Items]
Amount available in operating bank account $ 1,000,000
Working capital2,000,000
Loan amount from Sponsor outstanding $ 181,000
Notes Payable to Sponsor
Related Party Transaction [Line Items]
Loan amount from Sponsor outstanding181,000
Working Capital Loans
Related Party Transaction [Line Items]
Proceeds received from note payable to related party $ 25,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)3 Months Ended6 Months Ended
Jun. 30, 2021Mar. 31, 2021Jun. 30, 2021Feb. 05, 2021Dec. 31, 2020
Cash equivalents $ 1,000,000 $ 1,000,000
Cash and investments held in Trust Account402,521,993 402,521,993
Number of shares called by each warrants (in shares)1
Exercise price of warrant $ 11.50
Unrecognized tax benefits0 0 $ 0
Unrecognized tax benefits accrued for interest and penalties0 $ 0 $ 0
Anti-dilutive securities attributable to warrants (in shares)18,100,000
Net loss $ (4,023,943) $ (5,043,542) $ (9,067,485)
Class A ordinary shares subject to redemption
Class A ordinary shares subject to possible redemption35,395,781 35,395,781 0
Forward Purchase Agreement
Units issued during the period, value $ 200,000,000
Number of shares per unit1
Number of warrants in a unit0.15
Number of shares called by each warrants (in shares)1 1
Exercise price of warrant $ 11.50 $ 11.50
Purchase price per unit $ 10 $ 10
Private Placement Warrants
Number of shares called by each warrants (in shares)1 1
Exercise price of warrant $ 11.50 $ 11.50
Public Warrants
Exercise price of warrant $ 11.50 $ 11.50

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Correction of Financial Statement (Details) - USD ($)Jun. 30, 2021Dec. 31, 2020
Summary of Significant Accounting Policies
Derivative liabilities $ 29,158,500
Class A common stock subject to possible redemption353,957,810
Additional paid-in capital14,079,105 $ 23,494
Accumulated deficit $ (9,081,089) $ (13,604)

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($) $ / shares in Units, $ in MillionsFeb. 05, 2021Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Number of units sold in initial public offering40,250,000
Price per share $ 10
Proceeds from issuance of shares $ 402.5
Incurred offering costs22.7
Underwriting commissions $ 14.1
Exercise price of warrants $ 11.50
Number of Class A ordinary share in each unit1
Warrant in each unit (as percent)0.20%
Number of shares called by each warrants (in shares)1
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrants $ 11.50
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units sold in initial public offering5,250,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units sold in initial public offering5,250,000

Related Party Transactions - Fo

Related Party Transactions - Forward Purchase Agreement (Details) - USD ($)6 Months Ended
Jun. 30, 2021Feb. 05, 2021
Related Party Transaction [Line Items]
Number of shares per warrant1
Exercise price of warrants $ 11.50
Forward Purchase Agreement
Related Party Transaction [Line Items]
Units issued during the period, value $ 200,000,000
Number of shares in a unit1
Number of warrants in a unit0.15
Number of shares per warrant1
Exercise price of warrants $ 11.50
Purchase price per unit $ 10

Related Party Transactions - _2

Related Party Transactions - Founder Shares (Details) - USD ($)Jan. 14, 2021Jan. 13, 2021Aug. 14, 2020Jun. 30, 2021Feb. 05, 2021Dec. 31, 2020
Class A ordinary shares
Related Party Transaction [Line Items]
Common Stock, Shares, Outstanding4,854,219 0
Class B ordinary shares
Related Party Transaction [Line Items]
Common Stock, Shares, Outstanding15,062,500 15,062,500
Founder Shares [Member] | Class B ordinary shares
Related Party Transaction [Line Items]
Number of Founder Shares no longer subject to forfeiture1,312,500
Founder Shares [Member] | Sponsor
Related Party Transaction [Line Items]
Number of shares transferred (in shares)40,000
Shares subject to forfeiture1,312,500
Restrictions on transfer period of time after business combination completion1 year
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination30 days
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences150 days
Founder Shares [Member] | Sponsor | Class A ordinary shares
Related Party Transaction [Line Items]
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) $ 12
Founder Shares [Member] | Sponsor | Class B ordinary shares
Related Party Transaction [Line Items]
Number of shares issued22,250,000
Aggregate purchase price $ 0 $ 25,000
Number of shares surrender7,187,500
Common Stock, Shares, Outstanding15,062,500
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders20.00%
Purchase price, per unit $ 0.001

Related Party Transactions - Pr

Related Party Transactions - Private Placement Warrants (Details) - USD ($) $ / shares in Units, $ in MillionsFeb. 05, 2021Jun. 30, 2021
Related Party Transaction [Line Items]
Number of shares per warrant1
Exercise price of warrant $ 11.50
Private Placement Warrants
Related Party Transaction [Line Items]
Number of shares per warrant1
Exercise price of warrant $ 11.50
Private Placement
Related Party Transaction [Line Items]
Number of warrants to purchase shares issued (in shares)10,050,000
Aggregate purchase price $ 10.1
Private Placement | Private Placement Warrants
Related Party Transaction [Line Items]
Number of warrants to purchase shares issued (in shares)10,050,000
Price of warrants $ 1
Aggregate purchase price $ 10.1

Related Party Transactions - Re

Related Party Transactions - Related Party Loans (Details) - USD ($)May 20, 2021Jun. 30, 2021Feb. 05, 2021Aug. 14, 2020
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note $ 300,000
Outstanding balance of related party note $ 181,000
Repayments of Related Party Debt $ 181,088
Unsecured Promissory Notes Issued $ 1,000,000
Price Per Private Placement Warrant $ 1
Working capital loans warrant
Related Party Transaction [Line Items]
Price of warrants (in dollars per share) $ 1
Loans convertible into warrants $ 2,500,000
Proceeds received from note payable to related party1,000,000
Fair value of working capital loan $ 1,800,000

Related Party Transactions - Ad

Related Party Transactions - Administrative Support Agreement (Details) - USD ($)3 Months Ended6 Months Ended
Jun. 30, 2021Jun. 30, 2021Dec. 31, 2020
Related Party Transaction [Line Items]
Repayment of promissory note - related party $ 181,088
General and administrative expense $ 350,908 801,808
Accrued expenses - related party99,286 99,286
Administrative Support Agreement
Related Party Transaction [Line Items]
Office space, secretarial and administrative services per month20,000
General and administrative expense60,000 99,000
Accrued expenses - related party $ 99,000 $ 99,000 $ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)Feb. 05, 2021Jun. 30, 2021Dec. 31, 2020
Other Commitments [Line Items]
Units Issued During Period, Shares, New Issues40,250,000
Underwriting cash discount per unit $ 0.20
Underwriter cash discount $ 8,100,000
Deferred underwriting commission (in dollars per unit) $ 0.35
Deferred underwriting commissions in connection with the initial public offering $ 14,100,000
Deferred legal fees $ 436,000 $ 49,200
Initial Public Offering
Other Commitments [Line Items]
Units Issued During Period, Shares, New Issues5,250,000

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock Shares (Details) - $ / sharesJun. 30, 2021Dec. 31, 2020
Shareholders' Equity
Preferred shares, shares authorized1,000,000 1,000,000
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001
Preferred shares, shares issued0 0
Preferred shares, shares outstanding0 0

Shareholders' Equity - Common S

Shareholders' Equity - Common Stock Shares (Details)6 Months Ended
Jun. 30, 2021Vote$ / sharessharesDec. 31, 2020$ / sharesshares
Class A ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)500,000,000 500,000,000
Common shares, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common shares, votes per share | Vote1
Common shares, shares issued (in shares)4,854,219 0
Common shares, shares outstanding (in shares)4,854,219 0
Class A ordinary shares subject to redemption
Class of Stock [Line Items]
Class A common stock subject to possible redemption, outstanding (in shares)35,395,781 0
Class B ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)50,000,000 50,000,000
Common shares, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common shares, votes per share | Vote1
Common shares, shares issued (in shares)15,062,500 15,062,500
Common shares, shares outstanding (in shares)15,062,500 15,062,500
Initial Business Combination Shares Issuable As Percent Of Outstanding Share20.00%
Ratio to be applied to the stock in the conversion1

Derivative Liabilities (Details

Derivative Liabilities (Details)6 Months Ended
Jun. 30, 2021USD ($)D$ / sharessharesFeb. 05, 2021$ / sharesshares
Class of Warrant or Right [Line Items]
Exercise price of warrant $ 11.50
Number of shares called by each warrants (in shares) | shares1
Forward Purchase Agreement
Class of Warrant or Right [Line Items]
Exercise price of warrant $ 11.50
Units issued during the period, value | $ $ 200,000,000
Number of shares per unit | shares1
Number of warrants in a unit | shares0.15
Number of shares called by each warrants (in shares) | shares1
Purchase price per unit $ 10
Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of warrants, outstanding | shares10,050,000
Exercise price of warrant $ 11.50
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination30 days
Number of shares called by each warrants (in shares) | shares1
Private Placement Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share) $ 10
Redemption price per public warrant (in dollars per share) $ 0.10
Minimum threshold written notice period for redemption of public warrants30 days
Threshold trading days for redemption of public warrants | D20
Threshold consecutive trading days for redemption of public warrants | D30
Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants, outstanding | shares8,050,000
Public Warrants exercisable term after the completion of a business combination30 days
Public Warrants exercisable term from the closing of the public offering12 months
Exercise price of warrant $ 11.50
Public Warrants expiration term5 years
Maximum period after business combination in which to file registration statement20 days
Maximum threshold period for registration statement to become effective after business combination60 days
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share) $ 18
Redemption price per public warrant (in dollars per share) $ 0.01
Minimum threshold written notice period for redemption of public warrants30 days
Threshold trading days for redemption of public warrants | D20
Threshold consecutive trading days for redemption of public warrants | D30
Redemption period30 days

Fair Value Measurements - Recon

Fair Value Measurements - Reconciliation of the beginning and ending balances (Details)6 Months Ended
Jun. 30, 2021USD ($)
Acquisition date fair value of derivatives:
Total acquisition date fair value of derivative liabilities $ 41,735,500
Change in fair value of warrant liabilities(3,882,000)
Change in fair value of forward purchase agreement(8,695,000)
Balance at the ending29,158,500
fair value of the private warrants10,200,000
Forward Purchase Agreement
Acquisition date fair value of derivatives:
Total acquisition date fair value of derivative liabilities9,138,000
Public Warrants
Acquisition date fair value of derivatives:
Total acquisition date fair value of derivative liabilities12,397,000
Private Placement Warrants
Acquisition date fair value of derivatives:
Total acquisition date fair value of derivative liabilities $ 20,200,500

Fair Value Measurements - Fair

Fair Value Measurements - Fair values of assets (Details)Jun. 30, 2021USD ($)
Liabilities:
Derivative warrant liabilities $ 29,158,500
Level 1 | Recurring | Public Warrants
Liabilities:
Derivative warrant liabilities10,223,500
Level 1 | U.S. Treasury Securities | Recurring
Assets:
Investments held in Trust Account350,960,920
Level 3 | Recurring
Liabilities:
Working capital loan1,840,000
Level 3 | Recurring | Forward Purchase Agreement
Liabilities:
Derivative warrant liabilities443,000
Level 3 | Recurring | Private Placement Warrants
Liabilities:
Derivative warrant liabilities $ 18,492,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of derivative warrant liabilities (Details) - Level 3 - Recurring - USD ($)3 Months Ended
Jun. 30, 2021Mar. 31, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Derivative (assets) liabilities, beginning balance $ 17,066,500 $ 0
Issuance of Public and Private Placement Warrants22,447,000
Initial value of forward purchase agreement recognized as change in fair value of derivative assets and liabilities9,138,000
Initial excess fair value of Private Placement Warrants recognized in additional paid-in-capital10,150,500
Transfer of Public Warrants to Level 1(9,257,500)
Change in fair value of derivative warrant liabilities301,500 (5,149,500)
Change in fair value of forward purchase agreement1,567,000 (10,262,000)
Derivative (assets) liabilities, ending balance18,935,000 17,066,500
Forward Purchase Agreement
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Derivative (assets) liabilities, beginning balance(1,124,000)0
Initial value of forward purchase agreement recognized as change in fair value of derivative assets and liabilities9,138,000
Change in fair value of forward purchase agreement1,567,000 (10,262,000)
Derivative (assets) liabilities, ending balance443,000 (1,124,000)
Derivative Warrant Liabilities
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Derivative (assets) liabilities, beginning balance18,190,500 0
Issuance of Public and Private Placement Warrants22,447,000
Initial excess fair value of Private Placement Warrants recognized in additional paid-in-capital10,150,500
Transfer of Public Warrants to Level 1(9,257,500)
Change in fair value of derivative warrant liabilities301,500 (5,149,500)
Derivative (assets) liabilities, ending balance $ 18,492,000 $ 18,190,500

Fair Value Measurements - Fai_2

Fair Value Measurements - Fair value of working capital loans (Details) - Level 36 Months Ended
Jun. 30, 2021USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Initial fair value of working capital loan $ 1,000,000
Change in fair value of working capital loan840,000
Fair value at June 30, 2021 $ 1,840,000

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)3 Months Ended6 Months Ended
Jun. 30, 2021USD ($)Jun. 30, 2021USD ($)item$ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash $ 1,559,241 $ 1,559,241
Change in fair value of derivative liabilities2,800,000 $ 6,700,000
Probability of a successful business80.00%
Expected merger period after the Initial Public Offering date18 months
Number of Russell constituents | item3,000
Fair value assets level 1 to level 2 transfers0 $ 0
Fair value assets level 2 to level 1 transfers0 0
Fair value assets transferred into (out of) level 3 $ 0
Private placement converts warrants price | $ / shares $ 1
U.S. Treasury Securities | NAV Method
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amount of investments in an open-ended money market fund, in which the Company uses NAV as a practical expedient to fair value $ 50,001,832 $ 50,001,832

Fair Value Measurements - Chang

Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details) - Level 3Jun. 30, 2021$ / sharesY
Private Warrant | Stock price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input | $ / shares9.78
Private Warrant | Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input30
Private Warrant | Expected life of the options to convert
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input | Y5.5
Private Warrant | Risk-free rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input1
Private Warrant | Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input0
Forward Purchase Agreements | Stock price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input | $ / shares9.78
Forward Purchase Agreements | Risk-free rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input0.09
Forward Purchase Agreements | Probability of Merger Closing
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input80
Forward Purchase Agreements | Discount term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input | Y1.10